Potential for access to embryonic-like cells from human umbilical cord blood

Cell Proliferation

Volumn 41, Issue S1, 2008, Pages 31-40

  McGuckin, C P ^a   Forraz, N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULTHOOD; BIRTH; CELL POPULATION; CONFERENCE PAPER; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; ENDOTHELIUM; GENE MUTATION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE STATUS; LIVER REGENERATION; MEDICAL ETHICS; MICROGRAVITY; NEWBORN PERIOD; STEM CELL; STEM CELL TRANSPLANTATION; TELOMERE; TISSUE ENGINEERING; UMBILICAL CORD BLOOD;

ANIMALS; BONE MARROW CELLS; EMBRYONIC STEM CELLS; FETAL BLOOD; HUMANS; LIVER; TISSUE ENGINEERING;

EID: 37349027262     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2008.00490.x     Document Type: Conference Paper

References (40)

1. Atala A (2005) Tissue engineering, stem cells and cloning: current concepts and changing trends. Expert Opin. Biol. Ther. 5, 879 892.
2. Cohen Y, Nagler A (2004) Umbilical cord blood transplantation - how, when and for whom? Blood Rev. 18, 167 179.
3. Ende N, Lu S, Alcid MG, Chen R, Mack R (2001) Pooled umbilical cord blood as a possible universal donor for marrow reconstitution and use in nuclear accidents. Life Sci. 69, 1531 1539.
4. + umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis. Br. J. Haematol. 119, 516 524.
5. Forraz N, Pettengell R, McGuckin CP (2002b) Haemopoietic and neuroglial progenitors are promoted during cord blood ex vivo expansion. Br. J. Haematol. 119, 888.
6. Forraz N, Pettengell R, McGuckin CP (2004) Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Stem Cells 22, 100 108.
7. Forraz N, San-Choi B, Pettengell R, Morgan R, McGuckin CP (2003) Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Am. Soc. Cell Biol. Annu. Meeting, San Francisco, USA 1, 333 333.
8. Gerrard L, Zhao D, Clark AJ, Cui W (2005) Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells 23, 124 133.
9. +) hematopoietic stem cells. Exp. Hematol. 28, 1297 1305.
10. Heissig B, Ohki Y, Sato Y, Rafii S, Werb Z, Hattori K (2005) A role for niches in hematopoietic cell development. Hematology 10, 247 253.
11. Hoffman LM, Carpenter MK (2005) Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23, 699 708.
12. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM (2002) Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 30, 896 904.
13. Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R (2005) Human embryonic stem cells derived without feeder cells. Lancet 365, 1636 1641.
14. Kofidis T, Debruin JL, Tanaka M, Zwierzchoniewska M, Weissman I, Fedoseyeva E, Haverich A, Robbins RC (2005) They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur. J. Cardiothoracic Surg. 28, 461 466.
15. Korbling M, Estrov Z (2003) Adult stem cells for tissue repair - a new therapeutic concept? N. Engl. J. Med. 349, 570 582.
16. Krtolica A (2005) Stem cell: balancing aging and cancer. Int. J. Biochem. Cell Biol. 37, 935 941.
17. Landry DW, Zucker HA (2004) Embryonic death and the creation of human embryonic stem cells. J. Clin. Invest. 114, 1184 1186.
18. Li L, Xie T (2005) Stem cell niche: structure and function. Annu. Rev. Cell Dev. Biol. 21, 605 631.
19. Liu E, Law HK, Lau YL (2004) Tolerance associated with cord blood transplantation may depend on the state of host dendritic cells. Br. J. Haematol. 126, 517 526.
20. Martin MJ, Muotri A, Gage F, Varki A (2005) Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11, 228 232.
21. Matin MM, Walsh JR, Gokhale PJ, Draper JS, Bahrami AR, Morton I, Moore HD, Andrews PW (2004) Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22, 659 668.
22. McGuckin CP, Pearce D, Forraz N, Tooze JA, Watt SM, Pettengell R (2003a) Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur. J. Haematol. 71, 341 350.
23. McGuckin CP, Forraz N, Baradez MO, Lojo-Rial C, Wertheim D, Whiting K, Watt SM, Pettengell R (2003b) Colocalization analysis of sialomucins CD34 and CD164. Stem Cells 21, 162 170.
24. McGuckin CP, Forraz N, Liu WM (2003c) diaminofluorene stain detects erythroid differentiation in immature haemopoietic cells treated with EPO, IL-3, SCF, TGFbeta1, MIP-1alpha and IFNgamma. Eur. J. Haematol. 70, 106 114.
25. McGuckin CP, Forraz N, Allouard Q, Pettengell R (2004a) Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp. Cell Res. 295, 350 359.
26. McGuckin CP, Forraz N, Pettengell R, Thompson A (2004b) Thrombopoietin, flt3-Ligand and c-Kit-Ligand modulate HOX gene expression in expanding cord blood CD133 cells. Cell Prolif. 37, 295 306.
27. McGuckin CP, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, Tilton R, Denner L (2005) Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Proliferation 38, 245 255.
28. Nowlin A (2005) The promise of stem cells. RN 68, 48 52 quiz 53.
29. Perin EC, Silva GV (2004) Stem cell therapy for cardiac diseases. Curr. Opin. Hematol. 11, 399 403.
30. Prindull G (2005) Hypothesis: cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells? Exp. Hematol. 33, 738 746.
31. + cell selection from cryopreserved cord blood grafts for ex vivo expansion protocols. Transfusion 40, 625 631.
32. Quesenberry PJ, Dooner G, Colvin G, Abedi M (2005) Stem cell biology and the plasticity polemic. Exp. Hematol. 33, 389 394.
33. Rocha V, Wagner JE Jr., Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N. Engl. J. Med. 342, 1846 1854.
34. Rubinstein P, Adamson JW, Stevens C (1999) The placental/umbilical cord blood program of the new york blood center. A progress report. Ann. NY Acad. Sci. 872, 328 334 discussion 334 335.
35. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45 46.
36. Stojkovic M. Lako M. Strachan T, Murdoch A (2004) Derivation, growth and applications of human embryonic stem cells. Reproduction (Cambridge, England) 128, 259 267.
37. Tajima A, Tanaka T, Ebata T, Takeda K, Kawasaki A, Kelly JM, Darcy PK, Vance RE, Raulet DH, Kinoshita K, Okumura K, Smyth MJ, Yagita H (2003) Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo. J. Immunol. 171, 1715 1721.
38. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145 1147.
39. Wang L, Li L, Menendez P, Cerdan C, Bhatia M (2005) Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood 105, 4598 4603.
40. Watt SM, Contreras M (2005) Stem cell medicine: umbilical cord blood and its stem cell potential. Semin. Fetal Neonatal Med. 10, 209 220.